Publication Name	World Journal of Clinical Cases
Manuscript ID	17451
Country

Received	2015-03-08 14:52
Peer-Review Started	2015-03-08 15:17
To Make the First Decision	2015-03-20 14:34
Return for Revision	2015-03-28 17:57
Revised	2015-04-17 21:17
Second Decision	2015-05-07 09:57
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-05-18 17:06
Articles in Press	2015-05-18 17:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-07 19:10
Publish the Manuscript Online	2015-07-27 18:31

ISSN	2307-8960 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Minireviews
Article Title	How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer
Manuscript Source	Invited Manuscript
All Author List	Elissa R Price, Jasmine Wong, Rita Mukhtar, Nola Hylton and Laura J Esserman
Funding Agency and Grant Number
Corresponding Author	Elissa R Price, Assistant Professor, Department of Radiology and Biomedical Imaging, University of California, 1600 Divisadero Street, Room C-250, San Francisco, CA 94115, United States. elissa.price@ucsf.edu
Key Words	Breast; Magnetic resonance imaging; Neoadjuvant chemotherapy; Biomarkers; Phenotypes
Core Tip	Following neoadjuvant chemotherapy, breast magnetic resonance imaging (MRI) most accurately predicts surgical pathology in triple negative, Her2 positive and hormone receptor negative tumors, especially if they are of a solid imaging phenotype. In these cases, post-neoadjuvant chemotherapy (NAC) MRI is highly reliable for surgical planning. Hormone receptor positive cancers and those demonstrating non mass enhancement show lower concordance with surgical pathology, making surgical guidance more nebulous in these cases. Radiologists and surgeons must assess MRI response to NAC in the context of tumor subtype.
Publish Date	2015-07-27 18:31
Citation	Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ. How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World J Clin Cases 2015; 3(7): 607-613
URL	http://www.wjgnet.com/2307-8960/full/v3/i7/607.htm
DOI	http://dx.doi.org/10.12998/wjcc.v3.i7.607

Full Article (PDF)	WJCC-3-607.pdf
Full Article (Word)	WJCC-3-607.doc
Manuscript File	17451-Review.docx
Answering Reviewers	17451-Answering reviewers.pdf
Audio Core Tip	17451-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	17451-Conflict-of-interest statement.pdf
Copyright License Agreement	17451-Copyright assignment.pdf
Peer-review Report	17451-Peer-review(s).pdf
Scientific Misconduct Check	17451-Scientific misconduct check.pdf
Scientific Editor Work List	17451-Scientific editor work list.pdf